The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients
Authors:
Open Access
- 4 November 2024
- journal article
- review article
- Published by Taylor & Francis in Virulence
- Vol. 15 (1) , 2421987
Abstract
The COVID-19 pandemic and large-scale administration of multiple SARS-CoV-2 vaccines have attracted global attention to the short-term and long-term effects on the human immune system. An analysis of the "traces" left by the body's T-cell immune response is needed, especially for the prevention and treatment of breakthrough infections and long COVID-19 and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infections. T-cell receptor complementarity determining region 3 (TCR CDR3) repertoire serves as a target molecule for monitoring the effects, mechanisms, and memory of the T-cell response. Furthermore, it has been extensively applied in the elucidation of the infectious mechanism and vaccine refinement of hepatitis B virus (HBV), influenza virus, human immunodeficiency virus (HIV), and SARS-CoV. Laboratories worldwide have utilized high-throughput sequencing (HTS) and scTCR-seq to characterize, share, and apply the TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients. This article focuses on the comparative analysis of the diversity, clonality, V&J gene usage and pairing, CDR3 length, shared CDR3 sequences or motifs, and other characteristics of TCR CDR3 repertoire. These findings provide molecular targets for evaluating T-cell response effects and short-term and long-term impacts on the adaptive immune system following SARS-CoV-2 infection or vaccination and establish a comparative archive of T-cell response "traces."Keywords
Funding Information
- National Natural Science Foundation of China (82160279)
- Guizhou Provincial Hundred Level Talent Fund ((2018)5637)
- Natural Science Foundation of Guizhou Province (Guizhou Province-ZK [2022] General 300)
This publication has 73 references indexed in Scilit:
- Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cellsCell Reports, 2023
- Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infectionJournal of Medical Virology, 2022
- Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencingBlood Cells, Molecules, and Diseases, 2022
- Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stageGenes & Genomics, 2022
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and MortalityClinical Reviews in Allergy & Immunology, 2022
- Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and PneumoniaJournal of Clinical Immunology, 2021
- TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patientsJournal of Leukocyte Biology, 2021
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Partial recovery of disturbed V-J pairing profiles of T-cell receptor in people living with HIV receiving long-term antiretroviral therapyScience China Life Sciences, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020